SEPTIN9 and glioblastoma: Compared with control and scramble groups, both single and double Septin RNAi treatments significantly decreased the solid tumor mass (Fig. 8c), indicating that downregulating the expression of SEPT9 and SEPT2 in GBM cells suppresses their tumor formation in vivo.